Search

everythinglearnresearchcommunity

for

Search:↓

Immune cells in Hidradenitis suppurativa become more inflammatory and may be important for treatment targets.

COVID-19 and hypopituitarism (reduced pituitary gland function) are linked, with the latter's related health issues potentially worsening COVID-19 outcomes, and COVID-19 possibly increasing risk for pituitary complications.

COVID-19 can cause hair loss starting as early as 18 days after infection.

A protein called lfTSLP is important in causing allergic and other skin diseases and could be a target for treatment.

Interferons are effective for some skin conditions and cancers, but can have side effects and need more research for optimal use.

Hair microRNAs could be effective biomarkers for diagnosing scleroderma.

Cyclosporine-A can cause serious blood clots in the brain, so patients need careful monitoring.

Anti-acne medications may work by reducing the activity of a protein involved in acne development.

Effective treatments for severe alopecia areata are still lacking.

Biologic agents can be effective for rheumatic diseases but have risks like infections and require careful monitoring and patient information.

Platelet-rich plasma and stem cell therapies are accepted treatments for hair restoration, with specific protocols recommended for best results, but more standardization is needed in stem cell use.

Dengue virus can infect human hair follicle cells and may cause hair loss.

Hormonal therapy is effective for treating acne in adult women, especially with signs of high androgen levels.

Air pollution (PM10) increases skin inflammation and aging by reducing collagen and may trigger a repair response in skin cells.

Upadacitinib helped regrow hair in a severe alopecia areata patient but stopping treatment caused hair loss to return.

A child's hair loss from alopecia areata was fully reversed in five months using diet and supplements.

Dupilumab can both heal and cause hair loss.

Treg cell-based therapies might help treat hair loss from alopecia areata, but more research is needed to confirm safety and effectiveness.

The CD4 protein may play a role in the behavior of certain skin cells, affecting their growth, movement, and differentiation.

Finasteride improves immune response and reduces organ damage after trauma hemorrhage in mice.

COVID-19 vaccination does not significantly increase the risk of developing alopecia areata.

Contact immunotherapy can cause vitiligo in patients with autoimmune conditions.

Minoxidil helps prevent hair loss from chemotherapy in rats.

Growth factors and cytokines are important for hair growth and could potentially treat hair loss, but more research is needed to overcome challenges before they can be used in treatments.

The document concludes that various topical medications are effective for skin conditions but often cause skin irritation as a side effect.

Managing metabolic syndrome needs both lifestyle changes and medical treatments.

Higher MIF levels in alopecia areata patients suggest it could be a treatment target and disease predictor.

Targeting immune tolerance issues in Alopecia Areata could restore hair growth and maintain remission.

A patient with alopecia had hair regrowth with tofacitinib but developed a skin reaction, choosing to continue the treatment despite the side effect.

Topical diphencyprone helped regrow hair in mice and rats with a condition similar to human hair loss.